Evaluation of POC Lung Ultrasound Combined With Pressure-volume Curve to Titration Adjust PEEP for ARDS Lung Recruitment
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03076450|
Recruitment Status : Unknown
Verified April 2017 by Qiancheng Luo, Shanghai Pudong New Area Gongli Hospital.
Recruitment status was: Recruiting
First Posted : March 10, 2017
Last Update Posted : May 2, 2017
|Condition or disease||Intervention/treatment||Phase|
|Acute Respiratory Distress Syndrome||Device: Lung Ultrasound Diagnostic Test: Maximum Oxygenation||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||30 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Clinical Evaluation of Point-of-care Lung Ultrasound Combined With Pressure-volume Curve to Titration Adjust PEEP for ARDS Lung Recruitment|
|Actual Study Start Date :||March 1, 2017|
|Estimated Primary Completion Date :||March 1, 2018|
|Estimated Study Completion Date :||September 1, 2018|
Active Comparator: Maximum Oxygenation
Using PVC to set the initial peep, check ABG real-time, and according to PaO2+PaCO2≥400mmHg whether or not to adjust maintain PEEP.
Diagnostic Test: Maximum Oxygenation
Adjust PEEP real-time in term of PaO2+PaCO2≥400mmHg whether or not.
Experimental: Lung Ultrasound Re-aeration Score
Combine POC-LUS with PVC in set the initial peep, and then dynamic record LUS-RAS to feedback regulate PEEP.
Device: Lung Ultrasound
Adjust PEEP real-time in term of LUS-RAS chang.
- Lung Ultrasound re-aeration score, LUS-RAS [ Time Frame: 48 hours ]The score is composed of 12 different regions of chest wall checked by POC-LUS.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03076450
|Contact: Qiancheng Luo, MMemail@example.com|
|Pudong, Shanghai, China, 200135|
|Contact: Qiancheng Luo, MM 008613564781737 firstname.lastname@example.org|
|Principal Investigator:||Qiancheng Luo, MM||Shanghai Pudong New Area Gongli Hospital|